Please provide your email address to receive an email when new articles are posted on . A nasal spray version of the diuretic bumetanide showed equivalence to oral ...
This news release contains updated information from the researcher that was not in the abstract. CHICAGO, Nov. 18, 2024 — A new nasal spray form of the medication bumetanide may reduce the tissue ...
CHICAGO, IL—A novel way of taking the loop diuretic bumetanide—by nasal spray—is safe and well tolerated in healthy adults, according to preliminary randomized data. Diuretic concentrations achieved ...
CHICAGO -- A bumetanide nasal spray in development for heart failure was well-tolerated and showed reliable rates of absorption compared with oral and intravenous delivery in a phase I trial of ...
CHICAGO — A nasal spray formulation of bumetanide, a diuretic drug, could help treat heart failure by preventing the resistance that can develop to oral forms of the drug, a preliminary safety and ...
The need to intensify oral diuretic therapy in patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) is significantly decreased with finerenone (Kerendia; ...
For patients with chronic heart failure (HF) who have persistent congestion despite high doses of oral loop diuretics, the right way to intensify diuretics in the outpatient setting may be narrowed, ...
NATIONAL HARBOR, Md. — Oral sodium chloride supplementation during IV diuresis resulted in similar changes in serum creatinine and body weight at 96 hours vs. placebo in patients hospitalized for ...
Early initiation of the sodium glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback